Sign in or create an account to add this stock to your watchlist.
About Proto Labs (NYSE:PRLB)
Proto Labs, Inc., together with its subsidiaries, operates as an e-commerce enabled digital manufacturer of custom parts for prototyping and short-run production worldwide. It utilizes injection molding, computer numerical control machining, three-dimensional (3D) printing, and sheet metal fabrication to manufacture custom parts for developers and engineers who use 3D computer-aided design software to design products across a range of end markets. The company was founded in 1999 and is headquartered in Maple Plain, Minnesota.
Industry, Sector and Symbol
Industry Fabricated structural metal products
Sub-IndustryIndustrial Machinery
SectorIndustrial Products
SymbolNYSE:PRLB
CUSIP74371310
Phone763-479-3680
Debt
Debt-to-Equity RatioN/A
Current Ratio4.17
Quick Ratio3.94
Price-To-Earnings
Trailing P/E Ratio61.97
Forward P/E Ratio46.00
P/E Growth2.39
Sales & Book Value
Annual Sales$344.49 million
Price / Sales9.35
Cash Flow$2.6619 per share
Price / Cash44.93
Book Value$17.31 per share
Price / Book6.91
Profitability
EPS (Most Recent Fiscal Year)$1.93
Net Income$51.77 million
Net Margins15.49%
Return on Equity12.88%
Return on Assets11.56%
Miscellaneous
Employees2,266
Outstanding Shares26,930,000
Proto Labs (NYSE:PRLB) Frequently Asked Questions
What is Proto Labs' stock symbol?
Proto Labs trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRLB."
How will Proto Labs' stock buyback program work?
Proto Labs declared that its board has authorized a stock repurchase program on Monday, April 10th 2017, which permits the company to buyback $50,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to reacquire up to 3.3% of its shares through open market purchases. Shares buyback programs are often a sign that the company's board of directors believes its shares are undervalued.
How were Proto Labs' earnings last quarter?
Proto Labs Inc (NYSE:PRLB) posted its quarterly earnings results on Thursday, April, 26th. The industrial products company reported $0.71 EPS for the quarter, beating the Zacks' consensus estimate of $0.68 by $0.03. The industrial products company earned $107.70 million during the quarter, compared to analysts' expectations of $103.88 million. Proto Labs had a net margin of 15.49% and a return on equity of 12.88%. The company's revenue was up 34.3% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.51 EPS. View Proto Labs' Earnings History.
When is Proto Labs' next earnings date?
What price target have analysts set for PRLB?
3 brokers have issued 12 month target prices for Proto Labs' stock. Their predictions range from $84.00 to $92.00. On average, they expect Proto Labs' share price to reach $88.00 in the next year. View Analyst Ratings for Proto Labs.
Who are some of Proto Labs' key competitors?
Who are Proto Labs' key executives?
Proto Labs' management team includes the folowing people:
- Ms. Victoria M. Holt, CEO, Pres & Director (Age 60)
- Mr. John A. Way, CFO & Exec. VP of Devel. (Age 45)
- Dr. Arthur Richard Baker III, Chief Technology Officer (Age 50)
- Mr. David M. Fein, Chief Revenue Officer (Age 49)
- Dr. Robert Bodor, VP & GM of Americas (Age 45)
Has Proto Labs been receiving favorable news coverage?
Press coverage about PRLB stock has trended somewhat positive this week, Accern Sentiment Analysis reports. The research group identifies positive and negative press coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Proto Labs earned a coverage optimism score of 0.13 on Accern's scale. They also gave headlines about the industrial products company an impact score of 46.69 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.
Who are Proto Labs' major shareholders?
Proto Labs' stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (11.72%), Disciplined Growth Investors Inc. MN (3.44%), Stephens Investment Management Group LLC (2.45%), New York State Common Retirement Fund (2.01%), JPMorgan Chase & Co. (1.81%) and Dimensional Fund Advisors LP (1.65%). Company insiders that own Proto Labs stock include Arthur R Baker III, John B Goodman, John B Tumelty, Rainer Gawlick, Robert Bodor and Victoria M Holt. View Institutional Ownership Trends for Proto Labs.
Which institutional investors are selling Proto Labs stock?
PRLB stock was sold by a variety of institutional investors in the last quarter, including New York State Common Retirement Fund, Victory Capital Management Inc., Thrivent Financial for Lutherans, Lord Abbett & CO. LLC, Tiverton Asset Management LLC, UBS Group AG, JPMorgan Chase & Co. and Disciplined Growth Investors Inc. MN. Company insiders that have sold Proto Labs company stock in the last year include John B Goodman, John B Tumelty, Rainer Gawlick and Robert Bodor. View Insider Buying and Selling for Proto Labs.
Which institutional investors are buying Proto Labs stock?
PRLB stock was bought by a variety of institutional investors in the last quarter, including Summit Trail Advisors LLC, Matarin Capital Management LLC, BlackRock Inc., Carillon Tower Advisers Inc., Pier Capital LLC, Picton Mahoney Asset Management, California Public Employees Retirement System and Amundi Pioneer Asset Management Inc.. View Insider Buying and Selling for Proto Labs.
How do I buy shares of Proto Labs?
Shares of PRLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Proto Labs' stock price today?
One share of PRLB stock can currently be purchased for approximately $119.60.
How big of a company is Proto Labs?
Proto Labs has a market capitalization of $3.24 billion and generates $344.49 million in revenue each year. The industrial products company earns $51.77 million in net income (profit) each year or $1.93 on an earnings per share basis. Proto Labs employs 2,266 workers across the globe.
How can I contact Proto Labs?
Proto Labs' mailing address is 5540 Pioneer Creek Drive, Maple Plain MN, 55359. The industrial products company can be reached via phone at 763-479-3680 or via email at [email protected]
MarketBeat Community Rating for Proto Labs (PRLB)
MarketBeat's community ratings are surveys of what our community members think about Proto Labs and other stocks. Vote "Outperform" if you believe PRLB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PRLB will underperform the S&P 500 over the long term. You may vote once every thirty days.
Proto Labs (NYSE:PRLB) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
3 Wall Street analysts have issued ratings and price targets for Proto Labs in the last 12 months. Their average twelve-month price target is $88.00, suggesting that the stock has a possible downside of 26.42%. The high price target for PRLB is $92.00 and the low price target for PRLB is $84.00. There are currently 3 hold ratings for the stock, resulting in a consensus rating of "Hold."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Hold | Hold | Hold | Hold |
| Consensus Rating Score: | 2.00 | 2.00 | 2.00 | 2.00 |
| Ratings Breakdown: | 0 Sell Rating(s)
3 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
3 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
3 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $88.00 | $73.6667 | $73.6667 | $56.00 |
| Price Target Upside: | 26.42% downside | 25.55% downside | 25.55% downside | 24.32% downside |
Proto Labs (NYSE:PRLB) Consensus Price Target History
Proto Labs (NYSE:PRLB) Analyst Ratings History
Show:
(Data available from 5/22/2016 forward)
Proto Labs (NYSE:PRLB) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Proto Labs (NYSE PRLB) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 0.64%
Institutional Ownership Percentage: 95.92%
Proto Labs (NYSE PRLB) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 3/14/2018 | John B Goodman | Director | Sell | 1,114 | $122.71 | $136,698.94 | 11,091 |  |
| 2/13/2018 | Robert Bodor | VP | Sell | 1,891 | $106.00 | $200,446.00 | | |
| 2/12/2018 | John B Goodman | Director | Sell | 2,715 | $106.79 | $289,934.85 | | |
| 1/2/2018 | Rainer Gawlick | Director | Sell | 500 | $102.75 | $51,375.00 | 10,925 | |
| 12/11/2017 | Robert Bodor | VP | Sell | 4,000 | $94.79 | $379,160.00 | 20,578 | |
| 11/22/2017 | John B Tumelty | VP | Sell | 13,556 | $92.07 | $1,248,100.92 | | |
| 11/21/2017 | Rainer Gawlick | Director | Sell | 1,500 | $90.31 | $135,465.00 | 6,925 | |
| 7/27/2017 | Robert Bodor | VP | Sell | 741 | $73.84 | $54,715.44 | 17,319 | |
| 7/19/2017 | Robert Bodor | VP | Sell | 3,259 | $72.02 | $234,713.18 | 19,837 | |
| 5/22/2017 | Rainer Gawlick | Director | Sell | 833 | $64.05 | $53,353.65 | 6,258 | |
| 5/8/2017 | John B Tumelty | Director | Sell | 11,896 | $61.72 | $734,221.12 | 4,299 | |
| 2/15/2017 | John B Tumelty | VP | Sell | 862 | $56.78 | $48,944.36 | 17,057 | |
| 2/15/2017 | Victoria M Holt | Insider | Sell | 2,025 | $56.80 | $115,020.00 | 44,018 | |
| 9/1/2016 | Arthur R Baker III | Insider | Buy | 3,000 | $55.00 | $165,000.00 | 7,105 | |
| 5/19/2016 | Rainer Gawlick | Director | Sell | 357 | $61.20 | $21,848.40 | 3,007 | |
| 4/14/2016 | Rainer Gawlick | Director | Sell | 4,000 | $80.00 | $320,000.00 | 7,364 | |
| 4/4/2016 | Jacqueline D Schneider | VP | Sell | 19,844 | $77.66 | $1,541,085.04 | 24,827 | |
| 3/31/2016 | John B Tumelty | Director | Sell | 21,000 | $77.51 | $1,627,710.00 | 31,627 | |
| 3/7/2016 | John B Goodman | Director | Sell | 1,000 | $73.56 | $73,560.00 | 8,263 | |
| 2/17/2016 | Jacqueline D Schneider | VP | Sell | 313 | $63.52 | $19,881.76 | 10,827 | |
| 2/17/2016 | John B Tumelty | Director | Sell | 410 | $63.94 | $26,215.40 | 10,627 | |
| 8/17/2015 | John B Tumelty | Director | Sell | 9,400 | $73.83 | $694,002.00 | | |
| 7/23/2015 | Jacqueline D Schneider | VP | Sell | 30,000 | $74.75 | $2,242,500.00 | | |
| 7/1/2015 | John B Goodman | Director | Sell | 500 | $67.50 | $33,750.00 | | |
| 4/16/2015 | Donald G Krantz | VP | Sell | 1,195 | $79.00 | $94,405.00 | | |
| 4/15/2015 | Jacqueline D Schneider | VP | Sell | 2,000 | $77.80 | $155,600.00 | | |
| 4/13/2015 | John B Tumelty | Director | Sell | 21,000 | $75.07 | $1,576,470.00 | | |
| 10/3/2014 | John B Goodman | Director | Sell | 1,000 | $70.20 | $70,200.00 | | |
| 10/1/2014 | John B Goodman | Director | Sell | 2,000 | $68.35 | $136,700.00 | | |
| 7/31/2014 | John R Judd | CFO | Sell | 75,000 | $80.84 | $6,063,000.00 | | |
| 7/1/2014 | Jacqueline D Schneider | VP | Sell | 14,000 | $88.98 | $1,245,720.00 | | |
| 7/1/2014 | John B Goodman | Director | Sell | 3,000 | $82.91 | $248,730.00 | | |
| 6/26/2014 | Rainer Gawlick | Director | Sell | 1,000 | $80.42 | $80,420.00 | | |
| 4/2/2014 | John Goodman | Director | Sell | 6,762 | $71.16 | $481,183.92 | 6,250 | |
| 2/19/2014 | Lawrence Lukis | Chairman | Sell | 1,000,000 | $76.00 | $76,000,000.00 | 2,806,840 | |
| 2/13/2014 | Victoria Holt | CEO | Buy | 3,200 | $78.64 | $251,648.00 | 15,928 | |
| 2/7/2014 | Robert Bodor | CTO | Sell | 4,000 | $80.37 | $321,480.00 | | |
| 1/6/2014 | John Tumelty | Insider | Sell | 4,464 | $73.02 | $325,961.28 | | |
| 11/21/2013 | John Tumelty | Insider | Sell | 1,750 | $77.00 | $134,750.00 | | |
| 11/12/2013 | Jacqueline Schneider | VP | Sell | 2,000 | $88.90 | $177,800.00 | 1,250 | |
| 11/7/2013 | Bradley Cleveland | CEO | Sell | 134,564 | $81.97 | $11,030,211.08 | | |
| 11/5/2013 | Bradley Cleveland | CEO | Sell | 93,250 | $86.20 | $8,038,150.00 | | |
| 11/1/2013 | John B Goodman | Director | Sell | 2,000 | $83.88 | $167,760.00 | | |
| 10/31/2013 | John R Judd | CFO | Sell | 50,000 | $76.96 | $3,848,000.00 | | |
| 10/21/2013 | Jacqueline D Schneider | VP | Sell | 2,000 | $83.90 | $167,800.00 | | |
| 10/21/2013 | John B Tumelty | Insider | Sell | 1,750 | $83.09 | $145,407.50 | | |
| 9/23/2013 | Jacqueline Schneider | VP | Sell | 2,000 | $78.92 | $157,840.00 | 1,250 | |
| 9/23/2013 | John Tumelty | Insider | Sell | 1,750 | $78.00 | $136,500.00 | | |
| 9/23/2013 | Rainer Gawlick | Director | Sell | 17,500 | $77.71 | $1,359,925.00 | 2,250 | |
| 9/10/2013 | Bradley A Cleveland | CEO | Sell | 95,000 | $74.30 | $7,058,500.00 | | |
| 9/9/2013 | Jacqueline D Schneider | VP | Sell | 2,000 | $73.90 | $147,800.00 | | |
| 9/4/2013 | Brian K Smith | Director | Sell | 10,177 | $74.85 | $761,748.45 | | |
| 9/3/2013 | Margaret Loftus | Director | Sell | 10,000 | $71.97 | $719,700.00 | 61,250 | |
| 8/21/2013 | John Tumelty | Insider | Sell | 1,750 | $68.43 | $119,752.50 | | |
| 8/5/2013 | Brian Smith | Director | Sell | 40,000 | $68.48 | $2,739,200.00 | 10,177 | |
| 8/5/2013 | Lawrence Lukis | Chairman | Sell | 1,000,000 | $65.57 | $65,570,000.00 | 4,106,840 | |
| 8/1/2013 | John B Goodman | Director | Sell | 2,000 | $63.79 | $127,580.00 | | |
| 8/1/2013 | John Judd | CFO | Sell | 50,000 | $63.77 | $3,188,500.00 | | |
| 7/22/2013 | John B Tumelty | Insider | Sell | 1,750 | $64.00 | $112,000.00 | | |
| 7/8/2013 | John B Tumelty | Insider | Sell | 10,500 | $64.69 | $679,245.00 | | |
| 7/1/2013 | Rainer Gawlick | Director | Sell | 2,000 | $65.80 | $131,600.00 | | |
| 5/30/2013 | Margaret A Loftus | Director | Sell | 10,000 | $53.83 | $538,300.00 | | |
| 5/29/2013 | Rainer Gawlick | Director | Sell | 2,000 | $53.40 | $106,800.00 | | |
| 5/10/2013 | Jacqueline D Schneider | VP | Sell | 7,000 | $57.80 | $404,600.00 | | |
| 5/2/2013 | Brian K Smith | Director | Sell | 64,000 | $50.50 | $3,232,000.00 | | |
| 5/1/2013 | John B Goodman | Director | Sell | 2,000 | $50.60 | $101,200.00 | | |
| 4/30/2013 | Bradley A Cleveland | CEO | Sell | 5,000 | $50.52 | $252,600.00 | | |
| 4/10/2013 | Donald G Krantz | COO | Sell | 42,000 | $50.56 | $2,123,520.00 | | |
| 1/16/2013 | William M Dietrick | VP | Sell | 32,000 | $42.30 | $1,353,600.00 | | |
| 12/3/2012 | Donald G Krantz | COO | Sell | 5,000 | $36.45 | $182,250.00 | | |
| 11/26/2012 | Donald G Krantz | COO | Sell | 2,490 | $35.06 | $87,299.40 | | |
| 10/31/2012 | Bradley A Cleveland | CEO | Sell | 29,000 | $34.22 | $992,380.00 | | |
| 10/3/2012 | Bradley A Cleveland | CEO | Sell | 9,000 | $33.56 | $302,040.00 | | |
| 10/2/2012 | Jacqueline D Schneider | VP | Sell | 8,250 | $34.00 | $280,500.00 | | |
| 10/2/2012 | Mark R Kubicek | EVP | Sell | 5,000 | $34.00 | $170,000.00 | | |
| 9/6/2012 | Mark R Kubicek | EVP | Sell | 50,000 | $30.78 | $1,539,000.00 | | |
| 9/5/2012 | Margaret A Loftus | Director | Sell | 45,000 | $30.71 | $1,381,950.00 | | |
| 9/4/2012 | Bradley A Cleveland | CEO | Sell | 4,500 | $31.01 | $139,545.00 | | |
| 8/23/2012 | Brian K Smith | Director | Sell | 20,000 | $32.25 | $645,000.00 | | |
(Data available from 1/1/2013 forward)
Proto Labs (NYSE PRLB) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Proto Labs Inc (PRLB) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - May 21 at 11:13 AM |
| $109.81 Million in Sales Expected for Proto Labs Inc (PRLB) This Quarter
www.americanbankingnews.com - May 20 at 4:40 AM |
| Zacks: Brokerages Expect Proto Labs (PRLB) to Announce $0.73 Earnings Per Share
www.americanbankingnews.com - May 18 at 7:18 AM |
| Reviewing Proto Labs (PRLB) & Valmont Industries (VMI)
www.americanbankingnews.com - May 16 at 5:09 PM |
| Critical Review: Proto Labs (PRLB) and Valmont Industries (VMI)
www.americanbankingnews.com - May 14 at 1:18 AM |
| Harsco (HSC) & Proto Labs (PRLB) Head to Head Comparison
www.americanbankingnews.com - May 8 at 7:22 PM |
| Financial Review: Proto Labs (PRLB) vs. Valmont Industries (VMI)
www.americanbankingnews.com - May 7 at 5:26 AM |
| Comparing Valmont Industries (VMI) & Proto Labs (PRLB)
www.americanbankingnews.com - May 4 at 9:40 PM |
 | Free Post Earnings Research Report: Stanley Black & Decker's Quarterly Earnings Advanced 6.92%
finance.yahoo.com - May 4 at 8:46 AM |
| Proto Labs (PRLB) Stock Rating Upgraded by ValuEngine
www.americanbankingnews.com - May 2 at 10:54 PM |
 | Form 10-Q Proto Labs Inc For: Mar 31
www.streetinsider.com - May 2 at 8:45 AM |
| Recent Analysis Shows Waterstone Financial, Blue Bird, Proto Labs, American Assets Trust, MoSys, and Aratana Therapeutics Market Influences — Renewed Outlook, Key Drivers of Growth
finance.yahoo.com - May 2 at 8:45 AM |
| Proto Labs (PRLB) Expected to Announce Quarterly Sales of $108.79 Million
www.americanbankingnews.com - May 2 at 2:20 AM |
| Financial Analysis: Proto Labs (PRLB) vs. Valmont Industries (VMI)
www.americanbankingnews.com - May 1 at 5:09 AM |
| $0.70 Earnings Per Share Expected for Proto Labs (PRLB) This Quarter
www.americanbankingnews.com - April 30 at 7:20 PM |
 | Proto Labs Kicks Off 2018 With First-Quarter Earnings Growth of 39%
www.fool.com - April 29 at 8:43 AM |
| Proto Labs Kicks Off 2018 With First Quarter Earnings Growth of 39%
finance.yahoo.com - April 28 at 5:02 PM |
| Edited Transcript of PRLB earnings conference call or presentation 26-Apr-18 12:30pm GMT
finance.yahoo.com - April 27 at 4:55 PM |
| Proto Labs (PRLB) Posts Earnings Results
www.americanbankingnews.com - April 26 at 6:14 PM |
 | Proto Labs (PRLB) Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - April 26 at 4:56 PM |
| Proto Labs (PRLB) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - April 26 at 12:03 PM |
| Proto Labs beats by $0.03, beats on revenue
seekingalpha.com - April 26 at 8:51 AM |
| Proto Labs (PRLB) Beats on Q1 Earnings and Revenues
finance.yahoo.com - April 26 at 8:51 AM |
| Proto Labs (PRLB) vs. Valmont Industries (VMI) Head-To-Head Analysis
www.americanbankingnews.com - April 25 at 5:20 AM |
| Comparing Proto Labs (PRLB) & Valmont Industries (VMI)
www.americanbankingnews.com - April 25 at 1:18 AM |
| Proto Labs (PRLB) to Post Q1 Earnings: What's in the Offing?
finance.yahoo.com - April 23 at 4:52 PM |
| Proto Labs (PRLB) to Post Q1 Earnings: What's in the Offing?
finance.yahoo.com - April 23 at 4:52 PM |
| Proto Labs (PRLB) and Valmont Industries (VMI) Head to Head Review
www.americanbankingnews.com - April 20 at 1:26 AM |
 | Notable Thursday Option Activity: PRLB, IDTI, SWK
www.nasdaq.com - April 19 at 5:22 PM |
| Proto Labs (PRLB) Set to Announce Quarterly Earnings on Wednesday
www.americanbankingnews.com - April 18 at 3:28 AM |
| Proto Labs Inc (PRLB) Expected to Post Quarterly Sales of $98.81 Million
www.americanbankingnews.com - April 15 at 2:30 AM |
| Proto Labs Inc (PRLB) Expected to Announce Earnings of $0.69 Per Share
www.americanbankingnews.com - April 13 at 7:13 PM |
| Proto Labs (PRLB) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - April 11 at 11:00 AM |
| 3 Top Growth Stocks to Buy in April
finance.yahoo.com - April 11 at 9:26 AM |
| Protolabs Sets Conference Call to Discuss First Quarter 2018 Financial Results
finance.yahoo.com - April 10 at 4:58 PM |
| Proto Labs (PRLB) & Harsco (HSC) Head-To-Head Comparison
www.americanbankingnews.com - April 9 at 9:34 AM |
| Contrasting Proto Labs (PRLB) & HC2 (HCHC)
www.americanbankingnews.com - April 4 at 11:47 AM |
| Proto Labs (PRLB) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - April 1 at 9:48 PM |
| Proto Labs Inc (PRLB) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - April 1 at 11:22 AM |
| Zacks: Analysts Anticipate Proto Labs Inc (PRLB) Will Announce Quarterly Sales of $98.81 Million
www.americanbankingnews.com - March 29 at 4:00 AM |
| Proto Labs (PRLB) Lifted to "Buy" at Zacks Investment Research
www.americanbankingnews.com - March 26 at 7:08 PM |
| 5 Growth Investing Options in Industrial Products Sector
finance.yahoo.com - March 21 at 5:19 PM |
| Is It Too Late To Buy Proto Labs Inc (NYSE:PRLB)?
finance.yahoo.com - March 21 at 8:56 AM |
| Market Trends Toward New Normal in First Midwest, Virtus Investment Partners, Blue Bird, Ares Management, Proto Labs, and Lancaster Colony — Emerging Consolidated Expectations, Analyst Ratings
finance.yahoo.com - March 20 at 8:41 AM |
| Proto Labs Works for Capacity Expansion, Adds New Facility
finance.yahoo.com - March 19 at 5:10 PM |
| Proto Labs Inc (PRLB) Director Sells $136,698.94 in Stock
www.americanbankingnews.com - March 16 at 8:15 PM |
 | Proto Labs buys Brooklyn Park building, plans to add 150 new jobs
www.bizjournals.com - March 16 at 5:20 PM |
| Protolabs Expands Manufacturing Capacity with New Building, Added Machines
finance.yahoo.com - March 16 at 9:37 AM |
 | Top Ranked Growth Stocks to Buy for March 15th
www.zacks.com - March 15 at 10:02 AM |
| Top Ranked Growth Stocks to Buy for March 14th - Nasdaq
www.nasdaq.com - March 14 at 11:54 AM |
Proto Labs (NYSE:PRLB) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Proto Labs (NYSE:PRLB) Income Statement, Balance Sheet and Cash Flow Statement
Proto Labs (NYSE PRLB) Stock Chart for Tuesday, May, 22, 2018
Loading chart…
